JP2022546040A5 - - Google Patents

Info

Publication number
JP2022546040A5
JP2022546040A5 JP2022513127A JP2022513127A JP2022546040A5 JP 2022546040 A5 JP2022546040 A5 JP 2022546040A5 JP 2022513127 A JP2022513127 A JP 2022513127A JP 2022513127 A JP2022513127 A JP 2022513127A JP 2022546040 A5 JP2022546040 A5 JP 2022546040A5
Authority
JP
Japan
Prior art keywords
seq
dsrna
chain contains
optionally
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022513127A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022546040A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/073961 external-priority patent/WO2021037972A1/en
Publication of JP2022546040A publication Critical patent/JP2022546040A/ja
Publication of JP2022546040A5 publication Critical patent/JP2022546040A5/ja
Priority to JP2024180454A priority Critical patent/JP7892042B2/ja
Pending legal-status Critical Current

Links

JP2022513127A 2019-08-27 2020-08-27 Pcsk9を阻害するための組成物および方法 Pending JP2022546040A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024180454A JP7892042B2 (ja) 2019-08-27 2024-10-16 Pcsk9を阻害するための組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19306036 2019-08-27
EP19306036.5 2019-08-27
PCT/EP2020/073961 WO2021037972A1 (en) 2019-08-27 2020-08-27 Compositions and methods for inhibiting pcsk9

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024180454A Division JP7892042B2 (ja) 2019-08-27 2024-10-16 Pcsk9を阻害するための組成物および方法

Publications (2)

Publication Number Publication Date
JP2022546040A JP2022546040A (ja) 2022-11-02
JP2022546040A5 true JP2022546040A5 (cg-RX-API-DMAC7.html) 2023-09-04

Family

ID=67956661

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022513127A Pending JP2022546040A (ja) 2019-08-27 2020-08-27 Pcsk9を阻害するための組成物および方法
JP2024180454A Active JP7892042B2 (ja) 2019-08-27 2024-10-16 Pcsk9を阻害するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024180454A Active JP7892042B2 (ja) 2019-08-27 2024-10-16 Pcsk9を阻害するための組成物および方法

Country Status (5)

Country Link
US (1) US20220290156A1 (cg-RX-API-DMAC7.html)
EP (1) EP4022061A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022546040A (cg-RX-API-DMAC7.html)
CN (1) CN115176011B (cg-RX-API-DMAC7.html)
WO (1) WO2021037972A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11597744B2 (en) 2017-06-30 2023-03-07 Sirius Therapeutics, Inc. Chiral phosphoramidite auxiliaries and methods of their use
CN113166760A (zh) 2018-11-23 2021-07-23 赛诺菲 用于抑制angptl8的新型rna组合物和方法
US20220372063A1 (en) * 2019-09-05 2022-11-24 Sanofi Oligonucleotides containing nucleotide analogs
CN119451971A (zh) * 2022-06-27 2025-02-14 大睿生物医药科技(上海)有限公司 具有增强的稳定性的核苷酸替代物
JP2025532985A (ja) 2022-09-30 2025-10-03 アルナイラム ファーマシューティカルズ, インコーポレイテッド 修飾二本鎖rna剤
AU2024265748A1 (en) * 2023-05-04 2025-10-23 Argonaute RNA Limited Dual silencing
JP2026522625A (ja) * 2023-06-21 2026-07-08 セーンジーン バイオ ユーエスエー インコーポレイティド プロタンパク質転換酵素サブチリシン・ケキシン9型(pcsk9)を標的とする二本鎖rna、およびその使用方法
AU2024360473A1 (en) * 2023-11-06 2026-06-04 Hangzhou Tianlong Pharmaceutical Co., Ltd. Modification template for improving inhibitory effect of double-stranded oligonucleotide on target gene, combination thereof and use thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5665710A (en) 1990-04-30 1997-09-09 Georgetown University Method of making liposomal oligodeoxynucleotide compositions
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US5587308A (en) 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
JPH07509133A (ja) 1992-07-17 1995-10-12 リボザイム・ファーマシューティカルズ・インコーポレイテッド 動物疾患の処置のための方法および剤
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
US6054299A (en) 1994-04-29 2000-04-25 Conrad; Charles A. Stem-loop cloning vector and method
US5981501A (en) 1995-06-07 1999-11-09 Inex Pharmaceuticals Corp. Methods for encapsulating plasmids in lipid bilayers
JP4335310B2 (ja) 1995-06-07 2009-09-30 ザ ユニバーシティ オブ ブリティッシュ コロンビア 疎水性脂質−核酸複合中間体を通して調製される脂質−核酸粒子、及び遺伝子移送のための使用
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
DK1068311T3 (da) 1998-04-08 2011-08-08 Commw Scient Ind Res Org Fremgangsmåder og midler til opnåelse af modificerede fænotyper
AR020078A1 (es) 1998-05-26 2002-04-10 Syngenta Participations Ag Metodo para alterar la expresion de un gen objetivo en una celula de planta
ATE237312T1 (de) 1998-07-20 2003-05-15 Protiva Biotherapeutics Inc In liposomen verkapselte nukleinsäurekomplexe
BR9914772A (pt) 1998-10-09 2001-12-11 Ingene Inc Conjunto de elementos genéticos, vetor, célulahospedeira, conjunto para a produção de umasequência de ácido nucléico, método para aprodução in vivo ou in vitro de uma sequência deácido nucléico, transcrição de cdna, molécula deácido nucléico inibidor, transcrição de mrna,molécula heteroduplex e composiçãofarmacêutica
AU6298899A (en) 1998-10-09 2000-05-01 Ingene, Inc. Production of ssdna (in vivo)
DE19956568A1 (de) 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
CN100365122C (zh) * 2005-12-30 2008-01-30 中国疾病预防控制中心病毒病预防控制所 针对乙型流感病毒多聚酶基因的siRNA序列及其应用
US7605251B2 (en) * 2006-05-11 2009-10-20 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of the PCSK9 gene
CA2658183A1 (en) * 2006-07-17 2008-01-24 Sirna Therapeutics Inc. Rna interference mediated inhibition of proprotein convertase subtilisin kexin 9 (pcsk9) gene expression using short interfering nucleic acid (sina)
EP2229186A2 (en) 2007-12-04 2010-09-22 Alnylam Pharmaceuticals Inc. Carbohydrate conjugates as delivery agents for oligonucleotides
WO2010093788A2 (en) 2009-02-11 2010-08-19 Dicerna Pharmaceuticals, Inc. Multiplex dicer substrate rna interference molecules having joining sequences
NZ597504A (en) * 2009-06-15 2013-10-25 Alnylam Pharmaceuticals Inc Lipid formulated dsrna targeting the pcsk9 gene
WO2013154766A1 (en) * 2012-04-13 2013-10-17 New York University Microrna control of ldl receptor pathway
BR112015013105B1 (pt) * 2012-12-05 2022-02-08 Alnylam Pharmaceuticals, Inc Agente de rnai de fita dupla capaz de inibir a expressão de pcsk9, seus usos, composição farmacêutica e método de inibição da expressão de pcsk9 em uma célula in vitro
PL2992098T3 (pl) 2013-05-01 2019-09-30 Ionis Pharmaceuticals, Inc. Kompozycje i sposoby modulowania ekspresji hbv i ttr
CN112105625B (zh) * 2018-03-07 2024-12-31 赛诺菲 核苷酸前体、核苷酸类似物以及含其的寡聚化合物
CN112368381A (zh) * 2018-04-18 2021-02-12 迪克纳制药公司 用于治疗高胆固醇血症和相关病况的pcsk9靶向寡核苷酸

Similar Documents

Publication Publication Date Title
AU2018363840B2 (en) Nucleic acids for inhibiting expression of LPA in a cell
JP7249080B2 (ja) 可逆的に修飾されたオリゴヌクレオチドを含む組成物及びその使用
ES2924806T3 (es) Análogos de 4'-fosfato y oligonucleótidos que comprenden el mismo
JP2022513111A5 (cg-RX-API-DMAC7.html)
DK2431466T3 (en) Single-stranded nucleic acid molecule for the control of gene expression
EP2635681B1 (en) Base modified oligonucleotides
CN110573619B (zh) 抑制tmprss6基因表达的核酸产品和其用途
JP2022547888A5 (cg-RX-API-DMAC7.html)
EP2013344B1 (en) Antisense agents combining strongly bound base - modified oligonucleotide and artificial nuclease
CN119842706A (zh) 用于抑制细胞中lpa的表达的核酸
EP2857513A1 (en) Single-stranded nucleic acid molecule for regulating expression of gene having delivering function
TW201615835A (zh) 具有含氮脂環骨架之單股核酸分子(二)
CN113164768A (zh) 用于抑制tmprss6表达的核酸和铁螯合剂
WO2025016446A1 (en) Lipids and lipid nanoparticles
JP6974872B2 (ja) ヘテロ二本鎖型antimiR
CN119552122B (zh) 5'-磷酸酯修饰核苷及其制备方法与应用
HK40005478B (en) Compositions comprising reversibly modified oligonucleotides and uses thereof
HK40005478A (en) Compositions comprising reversibly modified oligonucleotides and uses thereof
HK40031790A (en) Nucleic acids for inhibiting expression of lpa in a cell